Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2556976930;76931;76932 chr2:178569427;178569426;178569425chr2:179434154;179434153;179434152
N2AB2392872007;72008;72009 chr2:178569427;178569426;178569425chr2:179434154;179434153;179434152
N2A2300169226;69227;69228 chr2:178569427;178569426;178569425chr2:179434154;179434153;179434152
N2B1650449735;49736;49737 chr2:178569427;178569426;178569425chr2:179434154;179434153;179434152
Novex-11662950110;50111;50112 chr2:178569427;178569426;178569425chr2:179434154;179434153;179434152
Novex-21669650311;50312;50313 chr2:178569427;178569426;178569425chr2:179434154;179434153;179434152
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAC
  • RefSeq wild type template codon: CTG
  • Domain: Ig-135
  • Domain position: 56
  • Structural Position: 141
  • Q(SASA): 0.8046
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/E rs1002726225 None 0.001 N 0.178 0.055 0.165133752707 gnomAD-4.0.0 2.73767E-06 None None None None I None 0 0 None 0 0 None 0 0 3.59851E-06 0 0
D/H None None 0.879 N 0.479 0.442 0.336400405673 gnomAD-4.0.0 1.5924E-06 None None None None I None 0 0 None 0 0 None 0 0 2.85984E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.2877 likely_benign 0.2874 benign -0.443 Destabilizing 0.338 N 0.507 neutral N 0.49836818 None None I
D/C 0.7386 likely_pathogenic 0.7441 pathogenic 0.096 Stabilizing 0.991 D 0.615 neutral None None None None I
D/E 0.1385 likely_benign 0.1337 benign -0.379 Destabilizing 0.001 N 0.178 neutral N 0.428084163 None None I
D/F 0.8037 likely_pathogenic 0.8108 pathogenic -0.412 Destabilizing 0.967 D 0.56 neutral None None None None I
D/G 0.2206 likely_benign 0.2201 benign -0.675 Destabilizing 0.505 D 0.468 neutral N 0.48988477 None None I
D/H 0.4407 ambiguous 0.4372 ambiguous -0.54 Destabilizing 0.879 D 0.479 neutral N 0.519340885 None None I
D/I 0.6116 likely_pathogenic 0.6121 pathogenic 0.131 Stabilizing 0.906 D 0.557 neutral None None None None I
D/K 0.5431 ambiguous 0.534 ambiguous 0.298 Stabilizing 0.404 N 0.473 neutral None None None None I
D/L 0.5558 ambiguous 0.5628 ambiguous 0.131 Stabilizing 0.826 D 0.493 neutral None None None None I
D/M 0.7723 likely_pathogenic 0.7765 pathogenic 0.473 Stabilizing 0.991 D 0.563 neutral None None None None I
D/N 0.1544 likely_benign 0.148 benign -0.031 Destabilizing 0.505 D 0.455 neutral N 0.501139127 None None I
D/P 0.6197 likely_pathogenic 0.607 pathogenic -0.038 Destabilizing 0.004 N 0.264 neutral None None None None I
D/Q 0.402 ambiguous 0.4073 ambiguous -0.005 Destabilizing 0.404 N 0.402 neutral None None None None I
D/R 0.5973 likely_pathogenic 0.5984 pathogenic 0.322 Stabilizing 0.826 D 0.501 neutral None None None None I
D/S 0.1925 likely_benign 0.1925 benign -0.175 Destabilizing 0.404 N 0.44 neutral None None None None I
D/T 0.3739 ambiguous 0.3764 ambiguous 0.012 Stabilizing 0.575 D 0.465 neutral None None None None I
D/V 0.3776 ambiguous 0.3808 ambiguous -0.038 Destabilizing 0.782 D 0.469 neutral N 0.511164119 None None I
D/W 0.9402 likely_pathogenic 0.9424 pathogenic -0.259 Destabilizing 0.991 D 0.647 neutral None None None None I
D/Y 0.4048 ambiguous 0.4096 ambiguous -0.159 Destabilizing 0.957 D 0.565 neutral N 0.512606914 None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.